| Gene symbol | IFNG | Synonyms | IFG, IFI, IMD69 | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12q15 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | interferon gamma | ||||
| GTO ID | GTC3334 |
| Trial ID | NCT05722691 |
| Disease | COVID-19 |
| Altered gene | IFNG |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | dsRNA |
| Treatment | RADAMINVIRO |
| Phase | Phase3 |
| Recruitment status | Completed |
| Title | Double-Blind, Placebo-Controlled Multicentre Clinical Study for Efficacy and Safety Assessment of the Drug RADAMINVIRO for COVID-19 Postexposure Prophylaxis |
| Year | 2022 |
| Country | Russian Federation |
| Company sponsor | Promomed, LLC |
| Other ID(s) | RAD-012022 |
| Cohort1: RADAMINVIRO | |||||||||
|
|||||||||
| Cohort2: Placebo | |||||||||
|
|||||||||